Fennec Pharmaceuticals (FENC) Net Income towards Common Stockholders Growth (1y) (2011 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -58.11% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -95.76% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -290.15% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 59.59% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -129.68% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -10.08% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,228.66% |
| 10 | Fennec Pharmaceuticals | 281.48 Mn | 244.70 Mn | 7.67 Mn | 242.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 242.11% |
| Sep 30, 2025 | 89.09% |
| Jun 30, 2025 | 42.77% |
| Mar 31, 2025 | -109.02% |
| Dec 31, 2024 | 42.67% |
| Sep 30, 2024 | -222.47% |
| Jun 30, 2024 | -2.55% |
| Mar 31, 2024 | 316.58% |
| Dec 31, 2023 | 61.08% |
| Sep 30, 2023 | 77.85% |
| Jun 30, 2023 | -6.31% |
| Mar 31, 2023 | -65.76% |
| Dec 31, 2022 | -58.04% |
| Sep 30, 2022 | -89.66% |
| Jun 30, 2022 | -29.10% |
| Mar 31, 2022 | 26.80% |
| Dec 31, 2021 | -27.69% |
| Sep 30, 2021 | 27.79% |
| Jun 30, 2021 | 18.87% |
| Mar 31, 2021 | -29.24% |
| Dec 31, 2020 | 7.00% |
| Sep 30, 2020 | -225.54% |
| Jun 30, 2020 | -2.66% |
| Mar 31, 2020 | -45.37% |
| Dec 31, 2019 | -19.87% |
| Sep 30, 2019 | 34.73% |
| Jun 30, 2019 | -81.44% |
| Mar 31, 2019 | -50.92% |
| Dec 31, 2018 | -19.98% |
| Sep 30, 2018 | -26.59% |
| Jun 30, 2018 | -75.85% |
| Mar 31, 2018 | -125.52% |
| Dec 31, 2017 | -117.83% |
| Sep 30, 2017 | -286.81% |
| Jun 30, 2017 | -109.38% |
| Mar 31, 2017 | -69.16% |
| Dec 31, 2016 | -107.62% |
| Sep 30, 2016 | -66.47% |
| Jun 30, 2016 | -26.16% |
| Mar 31, 2016 | -0.67% |
| Dec 31, 2015 | 30.25% |
| Sep 30, 2015 | 45.56% |
| Jun 30, 2015 | 40.06% |
| Mar 31, 2015 | 16.33% |
| Dec 31, 2014 | -89.45% |
| Sep 30, 2014 | -1,113.73% |
| Jun 30, 2014 | -0.11% |
| Mar 31, 2014 | -0.75% |
| Dec 31, 2013 | 62.47% |
| Sep 30, 2013 | 91.84% |
| Jun 30, 2013 | 25.42% |
| Mar 31, 2013 | 12.01% |
| Dec 31, 2012 | -25.11% |
| Sep 30, 2012 | 32.29% |
| Jun 30, 2012 | -117.63% |
| Mar 31, 2012 | 39.86% |
| Dec 31, 2011 | -10.31% |
| Sep 30, 2011 | -2.10% |
| Jun 30, 2011 | 77.05% |